相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus
B. Komoroski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies
L. Blonde et al.
DIABETES OBESITY & METABOLISM (2009)
Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity
Cendrine Cabou et al.
DIABETES (2008)
Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes
Susan Sam et al.
DIABETES (2008)
International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations
A. Ceriello et al.
DIABETIC MEDICINE (2008)
Development of multiple complications in type 2 diabetes is associated with the increase of multiple markers of chronic inflammation
Jawl-Shan Hwang et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2008)
Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes
Dennis Kim et al.
DIABETES CARE (2007)
The involvement of dopamine in the modulation of steep and waking
Jaime M. Monti et al.
SLEEP MEDICINE REVIEWS (2007)
Central glucagon like peptide-1 delays solid gastric emptying via central CRF and peripheral sympathetic pathway in rats
Yukiomi Nakade et al.
BRAIN RESEARCH (2006)
Cardiovascular disease risk factors predict the development of type 2 diabetes - The Insulin Resistance Atherosclerosis Study
RB D'Agostino et al.
DIABETES CARE (2004)
Population-based incidence rates and risk factors for a type 2 diabetes in white individuals - The Bruneck study
E Bonora et al.
DIABETES (2004)
Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance
DE Kelley et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes - The insulin resistance atherosclerosis study
A Festa et al.
DIABETES (2002)
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
AD Pradhan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Bromocriptine - A novel approach to the treatment of type 2 diabetes
H Pijl et al.
DIABETES CARE (2000)
分享论文
